Associations of lifestyle factors and anthropometric measures with repeat PSA levels during active surveillance/monitoring

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 10, 2012, Pages 1877-1885

  Burton, Anya J ^a   Martin, Richard M ^a   Donovan, Jenny L ^a   Lane, J Athene ^a   Davis, Michael ^a   Hamdy, Freddie C ^b   Neal, David E ^c   Tilling, Kate ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER EPIDEMIOLOGY; COHORT ANALYSIS; EXERCISE; FOLLOW UP; GLEASON SCORE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PATIENT MONITORING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; WAIST CIRCUMFERENCE;

AGED; BODY HEIGHT; COHORT STUDIES; DISEASE PROGRESSION; EXERCISE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SMOKING;

EID: 84867295796     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0411     Document Type: Article

References (38)

1. Soloway MS, Soloway CT, Eldefrawy A, Acosta K, Kava B, Manoharan M. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 2010;58:831-5.
2. Albertsen PC. When is active surveillance the appropriate treatment for prostate cancer? Acta Oncol 2011;50:120-6.
3. van Leeuwen PJ, Connolly D, Gavin A, Roobol MJ, Black A, Bangma CH, et al. Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit. Eur J Cancer 2010;46:377-83.
4. Frankel S, Smith GD, Donovan J, Neal D. Screening for prostate cancer. Lancet 2003;361:1122-8. (Pubitemid 36369568)
5. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005;293:2095-101. (Pubitemid 40617061)
6. Patel MI, DeConcini DT, Lopez-Corona E, Ohori M, Wheeler T, Scardino PT. An analysis of men with clinically localized prostate cancer who deferred definitive therapy. J Urol 2004;171:1520-4. (Pubitemid 38365409)
7. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126-31.
8. Cooperberg MR, Carroll PR, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol 2011;29:3669-76.
9. Albertsen P. Further support for active surveillance in the management of low-volume, low-grade prostate cancer. Eur Urol 2010;58:836-7.
10. van den Bergh RCN, Roemeling S, Roobol MJ, Aus G, Hugosson J, Rannikko AS, et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 2009;55:1-8.
11. Tosoian JJ, Trock BJ, Landis P, Feng Z, Epstein JI, Partin AW, et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 2011;29:2185-90.
12. Kristal AR, Chi C, Tangen CM, Goodman PJ, Etzioni R, Thompson IM. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 2006;106:320-8. (Pubitemid 43100440)
13. Skolarus TA, Wolin KY, Grubb RL III. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Nat Clin Pract Urol 2007;4:605-14. (Pubitemid 350130557)
14. Oremek GM, Seiffert UB. Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations. Clin Chem 1996;42:691-5. (Pubitemid 26142086)
15. Lane JA, Hamdy FC, Martin RM, Turner EL, Neal DE, Donovan JL. Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies. Eur J Cancer 2010;46:3095-101.
16. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985;10:141-6.
17. Jacobs DR, Ainsworth BE, Hartman TJ, Leon AS. A simultaneous evaluation of 10commonly used physical-activity questionnaires. Med Sci Sport Exerc 1993;25:81-91. (Pubitemid 23027686)
18. Miller DJ, Freedson PS, Kline GM. Comparison of activity levels using the Caltrac(R) accelerometer and 5 questionnaires. Med Sci Sport Exerc 1994;26:376-82. (Pubitemid 24088804)
19. Tilling K, Garmo H, Metcalfe C, Holmberg L, Hamdy FC, Neal DE, et al. Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts. Eur Urol 2010;57:446-52.
20. Akaike H. New look at statistical-model identification. IEEE Trans Autom Control 1974;Ac19:716-23.
21. Association AU. Prostate specific antigen best practice statement: 2009 update. 2009; [cited 2011 Nov 14]. Available from: http://www.auanet.org/ content/guidelines-and-quality-care/clinical-guidelines/main-reports/psa09.pdf.
22. Excellence NIfHaC. Prostate cancer: diagnosis and treatment. 2008; [cited 2011 Nov 14]. Available from: http://www.nice.org.uk/nicemedia/live/11924/ 39687/39687.pdf.
23. Algotar AM, Stratton SP, Ranger-Moore J, Stratton MS, Hsu CH, Ahmann FR, et al. Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer. Am J Mens Health 2011;5:272-8.
24. Oliver SE. PhD Thesis. Bristol, UK: University of Bristol; 2002.
25. White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med 2010;29:2920-31.
26. Loeb S, Yu X, Nadler RB, Roehl KA, Han M, Hawkins SA, et al. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy? J Urol 2007;177:102-6. (Pubitemid 44895330)
27. Bosch JLHR, Tilling K, Bohnen AM, Bangma CH, Donovan JL. Establishing normal reference ranges for prostate volume change with age in the population-based Krimpen-study: prediction of future prostate volume in individual men. Prostate 2007;67:1816-24. (Pubitemid 350228733)
28. Wright JL, Lin DW, Stanford JL. The effect of demographic and clinical factors on the relationship between BMI and PSA levels. Prostate 2011;71:1631-7.
29. Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res 2011;4:486-501.
30. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2007;16:63-9. (Pubitemid 46174265)
31. MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006;17:989-1003. (Pubitemid 44290764)
32. Andersson SO, Wolk A, Bergstrom R, Adami HO, Engholm G, Englund A, et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997;89:385-9. (Pubitemid 27102604)
33. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E. Smoking and prostate cancer survival and recurrence. JAMA 2011;305:2548-55.
34. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 2011;29:726-32.
35. Zuccolo L, Harris R, Gunnell D, Oliver S, Lane JA, Davis M, et al. Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:2325-36.
36. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1997;6:557-63. (Pubitemid 27342677)
37. Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 2000;88:674-84. (Pubitemid 30056945)
38. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005;23:5814-30.